The Analysis of the Factors Determining Efficiency of Vaccination against Tick-Borne Encephalitis
https://doi.org/10.31631/2073-3046-2016-15-2-72-76
Abstract
Long-term persistence of immunity was assessed in 1756 healthy adults (4 - 74 years of age) with documented immunization against tick-borne encephalitis. Serologic studies indicate that the protective immunity is associated with age, number of vaccine doses and time since the last vaccine dose. 411 persons were vaccinated against tick-borne encephalitis over 10 years ago. Most of them (67,5%) had protective antibodies. In some cases, the immunity lasts up to 34 years after last vaccination.
About the Authors
L. D. Shchuchinova
Federal service on customers’ rights protection and human well-being surveillance in the Altai Republic
Russian Federation
Russian Federation
L. V. Shchuchinov
Federal service on customers’ rights protection and human well-being surveillance in the Altai Republic
Russian Federation
Russian Federation
V. I. Zlobin
Irkutsk State Medical University
Russian Federation
Russian Federation
References
1. Leonova G.N. Vaccinal prevention of tick-borne encephalitis in the past, present and future. Bulletin of the SB RAMS. 2011; 4: 79 – 85 (in Russian).
2. Esjunina M.S. Modern trends in the incidence of tick-borne encephalitis in a variety of tactics immunization and improving epidemiological surveillance and control: Doctorate of med. sci. diss. Perm; 2015 (in Russian).
3. Pogodina V.V., Skrynnik S.M., Sagajdak O.A., Gerasimov S.G., Shherbinina M.S., Rumjanceva Z.N. The structure of immunity to tick-borne encephalitis in the population in the early and late period. Molecular diagnostics. Moscow. 2014; 1: 501 – 502 (in Russian).
4. Paulke-Korinek M., Kundi M., Laaber B., Brodtraeger N., Seidl-Friedrich C. et al. Factors associated with seroimmunity against tick borne encephalitis virus 10 years after booster vaccination. Vaccine. 2013; 31 (9): 1293 – 1297.
5. Schosser R., Reichert A., Mansmann U., Unger B., Heininger U., Kaiser R. Irregular tick-borne encephalitis vaccination schedules: The effect of a single catchup vaccination with FSME-IMMUN. A prospective non-interventional study. Vaccine. 2014; 32: 2375 – 2381.
6. Lindblom P., Wilhelmsson P., Fryland L., Matussek A., Haglund M., Sjöwall J. et al. Factors determining immunological response to vaccination against tickborne encephalitis virus in older individuals. PLoS One. 2014; 9(6): e100860.
7. Rendi-Wagner P., Paulke-Korinek M., Kundi M., Wiedermann U., Laaber B. et al. Antibody persistence following booster vaccination against tick-borne encephalitis: 3-Year post-booster follow-up. Vaccine. 2007; 25: 5097 – 5101.
8. Loew-Baselli A., Poellabauer E-M., Pavlova B.G., Fritsch S., Koska M. et al. Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18–67 years. Hum. Vaccin. 2009; 5: 551 – 556.
9. Weinberger B., Keller M., Fischer K-H., Stiasny K., Neuner C. et al. Decreased antibody titers and booster responses in tick-borne encephalitis vaccinees aged 50 – 90 years. Vaccine. 2010; 28: 3511 – 3515.
10. Baldovin T., Mel R., Bertoncello C., Carpenè G., Soppelsa F., Giliberti A. et al. Persistence of immunity to tick-borne encephalitis after vaccination and natural infection. J. Med. Virol. 2012; 84 (8): 1274 – 1278.
11. Weinberger B., Grubeck-Loebenstein B. Vaccines for the elderly. Clin. Microbiol. Infect. 2012;18: 100 – 108.
Review
For citations:
Shchuchinova L.D., Shchuchinov L.V., Zlobin V.I. The Analysis of the Factors Determining Efficiency of Vaccination against Tick-Borne Encephalitis. Epidemiology and Vaccinal Prevention. 2016;15(2):72-76. (In Russ.) https://doi.org/10.31631/2073-3046-2016-15-2-72-76
Views:
912
Email this article 